Document is current

Article History

Received: 9 August 2023

Accepted: 14 November 2023

First Online: 24 November 2023

Declarations

:

: LV reported receiving grants from the Swedish Research Council, Malmö University Hospital and Skåne University Hospital, Allmänna Sjukhusets i Malmö Stiftelse för bekämpande av cancer (the Malmö General Hospital Foundation for Fighting Against Cancer), Avtal om läkarutbildning och forskning (ALF)–medel, and Landstingsfinansierad Regional Forskning during the conduct of the study; and teaching fees from Samsung outside the submitted work. DT and BVC reported receiving grants from the Research Foundation–Flanders (FWO) and Internal Funds KU Leuven during the conduct of the study. TB reported receiving grants from NIHR Biomedical Research Centre, speaking honoraria and departmental funding from Samsung Healthcare and grants from Roche Diagnostics, Illumina, and Abbott. No other disclosures were reported. All other authors declare no competing interests.

: All mother studies received ethics approval from the Research Ethics Committee of the University Hospitals Leuven and from each local ethics committee. All participants provided informed consent. All methods were carried out in accordance with relevant guidelines and regulations. We obtained approval from the Ethics Committee in Leuven (S64709) for secondary use of the data for methodological purposes.

: Not applicable.